Product Detail
Emtricitabine Impurity
Emtricitabine Impurity
Stock Status: In Stock
Login to view price
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Impurity
API Family
Emtricitabine
Storage
Store at refrigerator (2-8°C) for long term storage
Hazard Information
Refer MSDS for accurate information.
Emtricitabine Impurity Product Information
Emtricitabine Impurity is listed under Impurity. It is associated with Emtricitabine and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-47837.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
Emtricitabine Impurity
CAS No.
764659-72-5
CAT No.
CS-T-47837
Molecular Formula
C18H26FN3O4S
Molecular Weight
399.5
Category
API Family
Storage Condition
Store at refrigerator (2-8°C) for long term storage
SMILES
O=C1N([C@H]2O[C@@H](C(O[C@H](C[C@H](C)CC3)[C@@H]3C(C)C)=O)SC2)C=C(F)C(N)=N1
IUPAC Name
(2R,5S)-5-(4-Amino-5-fluoro-2-oxo-1,2-dihydro-1-pyrimidinyl)-1,3-oxathiolane-2-carboxylic acid (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl ester
Purity by HPLC
Not less than 90%
Hazard Compound
Refer MSDS for accurate information.
Description
Overview
"An intermediate in the synthesis of Emtricitabine (). A reverse transcriptase inhibitor. It is an effective antiviral agent against HIV, HBV, and other viruses replicating in a similar manner. A nucleoside analog structurally related to Lamivudine . "
Synonyms
Emtricitabine Menthyl Ester Impurity
Application Notes
"An intermediate in the synthesis of Emtricitabine (). A reverse transcriptase inhibitor. It is an effective antiviral agent against HIV, HBV, and other viruses replicating in a similar manner. A nucleoside analog structurally related to Lamivudine . "
References
"Schinazi, R,F,, et al,: Antimicrob, Ag, Chemother,, 36, 2423 (1992), Shockeor, J,P,, et al,: Xenobioica, 26, 189 (1996), Feng, J,Y,, et al,: FASEB J,, 13, 1511 (1999), Molina, J,-M,, et al,: J, Infec, Dis,, 182, 599 (2000)"